David Armstrong, MD, PhD
PGY-L7
Division
Cardiovascular Medicine
Residency: University of Toronto
Professional Bio
David Armstrong, MD, PhD, is a physician-scientist with a special interest in innovative therapeutics and devices to treat and diagnose cardiovascular disease. He completed basic science training at Queen's University in Kinston, Canada, and clinical research training at the Kingston Heart Clinic. He completed residency training in Internal Medicine at the University of Toronto, and fellowship training in Cardiovascular Medicine at Vanderbilt University Medical Center. His research has been referenced in guidelines from the American Heart Association and American College of Cardiology. He currently has a particular focus on natriuretic peptide-based therapies for diseases with a need for effective therapies, such as hypertrophic cardiomyopathy and aortic stenosis. His research uses in vitro and genetic animal models to identify novel mechanisms and therapeutic targets, with a focus on CNP-based signaling to prevent cardiac fibrosis and aortic stenosis. He also utilizes human samples from the Cardiovascular Core Lab for Translational & Clinical Research to enhance the understanding and impact of basic and translational research to improve patient care. Dr. Armstrong also has research interests focusing on innovative devices for heart failure and cardiovascular imaging, which has produced two provisional patents.